A randomized, controlled trial of simvastatin versus rosuvastatin in patients with acute myocardial infarction: the Secondary Prevention of Acute Coronary Events--Reduction of Cholesterol to Key European Targets Trial

Alistair S Hall, Beryl M Jackson, Amanda J Farrin, Maria Efthymiou, Julian H Barth, Joanne Copeland, Kristian M Bailey, Simon P R Romaine, Anthony J Balmforth, Terry McCormack, Andrew Whitehead, Marcus D Flather, Jane Nixon, SPACE ROCKET Trial Group, Gordon Murray

Research output: Contribution to journalArticlepeer-review

Abstract

We sought to evaluate reports that rosuvastatin 10 mg is a more efficacious treatment of hyperlipidaemia than is simvastatin 40 mg, hoping to assess this issue in the previously unstudied context of acute myocardial infarction.
Original languageEnglish
Pages (from-to)712-21
Number of pages10
JournalEuropean journal of preventive cardiology
Volume16
Issue number6
DOIs
Publication statusPublished - 2009

Fingerprint

Dive into the research topics of 'A randomized, controlled trial of simvastatin versus rosuvastatin in patients with acute myocardial infarction: the Secondary Prevention of Acute Coronary Events--Reduction of Cholesterol to Key European Targets Trial'. Together they form a unique fingerprint.

Cite this